Another study showed reductions in body weight, but not in glycated hemoglobin A1c (HbA 1c ), in patients with obesity treated with JNJ-64565111 dualAG 8
They may want to lower your dose or try a different medication
This positions FOXO4-DRI within advanced molecular longevity research rather than endocrine or metabolic peptide categories
By enhancing GLP-1 hormone effects, it controls blood sugar, promotes weight loss, and reduces cardiovascular risks
GLP-1 medications also carry some serious (but rare) warnings: Potential risk of thyroid C-cell tumors (observed in rodent studies, unclear relevance in humans) Risk of gallbladder problems Pancreatitis (rare but documented) Hair loss (temporary, related to rapid weight loss rather than the drug itself) One notable advantage of GLP-1 medications: they do not cause cognitive dysfunction, do not carry teratogenicity warnings as severe as topiramate, and are not controlled substances
Free Rad